186 related articles for article (PubMed ID: 4718770)
41. [Value of amniotic fluid-serum HPL quotients for the monitoring of pregnancies at risk].
During R; Kunkel S
Zentralbl Gynakol; 1978; 100(9):589-93. PubMed ID: 676576
[TBL] [Abstract][Full Text] [Related]
42. [Radioimmunoassay of somatotropin (STH) and placental lactogen (HPL) during normal pregnancy].
Janisch H; Spona J
Wien Klin Wochenschr; 1973 Mar; 85(11):167-9. PubMed ID: 4691816
[No Abstract] [Full Text] [Related]
43. [Significance of chorionic somatomammotrophin levels under various conditions of a pregnant woman].
Proto M; Guidobono F; Pecile A
Minerva Ginecol; 1974 Nov; 26(11):681-4. PubMed ID: 4444809
[No Abstract] [Full Text] [Related]
44. [Monitoring of at-risk pregnancies through E3 and HPL].
Bieglmayer C; Spona J
Acta Univ Palacki Olomuc Fac Med; 1981; 101():38-42. PubMed ID: 6242692
[No Abstract] [Full Text] [Related]
45. [Diagnostic assessment of normal and risk pregnancies. 1. Comparison of two radioimmunological methods for the determination of human placental lactogen (author's transl)].
Musch K; Wolf AS; Lauritzen C
Geburtshilfe Frauenheilkd; 1978 May; 38(5):365-70. PubMed ID: 648860
[TBL] [Abstract][Full Text] [Related]
46. [Clinico-statistical correlations between HPL and neonatal weight and Apgar index].
Basile F; Weisz G; Bini P; Giaretto G
Minerva Ginecol; 1978 Dec; 30(12):1089-96. PubMed ID: 105330
[No Abstract] [Full Text] [Related]
47. Human placental lactogen in high-risk pregnancy.
Spellacy WN
Clin Obstet Gynecol; 1973 Mar; 16(1):298-312. PubMed ID: 4196839
[No Abstract] [Full Text] [Related]
48. [Clinical indications for targeted long-term monitoring of risk pregnancy using radioimmunologic HPL determination].
Herter U; Alexander H; Radzuweit H
Acta Univ Palacki Olomuc Fac Med; 1981; 101():50-6. PubMed ID: 6211054
[No Abstract] [Full Text] [Related]
49. Peptide hormones in assessing fetal status.
Spellacy WN
Clin Perinatol; 1974 Mar; 1(1):65-72. PubMed ID: 4470050
[No Abstract] [Full Text] [Related]
50. [Radioimmunologic determination of estriol, HPL, and alpha fetoprotein in maternal serum and their values in pregnancies at risk (proceedings)].
Arnold P; Rauskolb R; Jovanović V; Bleyl H
Arch Gynakol; 1977 Jul; 224(1-4):123-4. PubMed ID: 74991
[No Abstract] [Full Text] [Related]
51. [Human Placental Lactogen (HPL) in the diagnosis of risk pregnancy].
Stiglmayer R
Jugosl Ginekol Opstet; 1976; 16(1):53-8. PubMed ID: 966806
[No Abstract] [Full Text] [Related]
52. Amniotic, urinary and serum hormones in fetal diagnosis.
Farquhar JW
Can Med Assoc J; 1971 Jul; 105(2):174-6 passim. PubMed ID: 4933694
[No Abstract] [Full Text] [Related]
53. [Urinary estriol, serum HPL and intrauterine retardation of fetal growth].
Iarŭkov A
Akush Ginekol (Sofiia); 1987; 26(1):20-4. PubMed ID: 3592103
[No Abstract] [Full Text] [Related]
54. Elevated levels of b-human chorionic gonadotropin and human placental lactogen between 11-13 weeks' gestation and subsequent pregnancy complications in Omani women.
Krolikowski A; Al Busaidi F; Al Wahaibi A
Saudi Med J; 2004 Mar; 25(3):382-4. PubMed ID: 15048184
[No Abstract] [Full Text] [Related]
55. Radioimmunoassay of serum SP 1 and HPL in normal and abnormal pregnancies.
Pluta M; Hardt W; Schmidt-Gollwitzer K; Schmidt-Gollwitzer M
Arch Gynecol; 1979; 227(4):327-36. PubMed ID: 316310
[TBL] [Abstract][Full Text] [Related]
56. [Clinical indications for the purposeful monitoring of at-risk pregnancies using radioimmunological HPL determinations].
Herter U; Alexander H; Radzuweit H
Acta Univ Palacki Olomuc Fac Med; 1981; 101():50-6. PubMed ID: 6242694
[No Abstract] [Full Text] [Related]
57. Serum concentration of human placental lactogenic hormone (HPL) in pregnancy complications.
Seppälä M; Ruoslahti E
Acta Obstet Gynecol Scand; 1970; 49(2):143-7. PubMed ID: 4997062
[No Abstract] [Full Text] [Related]
58. [Serum HPL, total estrogen excretion and serum oxytocinase in intrauterine retardation. Results of 3 evaluation procedures].
Kyank HR
Zentralbl Gynakol; 1983; 105(10):635-41. PubMed ID: 6880465
[TBL] [Abstract][Full Text] [Related]
59. Plasma levels of pregnancy-specific beta 1-glycoprotein in complicated pregnancies.
Towler CM; Horne CH; Jandial V; Campbell DM; MacGillivray I
Br J Obstet Gynaecol; 1977 Apr; 84(4):258-63. PubMed ID: 870010
[TBL] [Abstract][Full Text] [Related]
60. Human placental lactogen and pregnancy-associated plasma protein A in first trimester and subsequent fetal growth.
Pedersen JF; Sørensen S; Ruge S
Acta Obstet Gynecol Scand; 1995 Aug; 74(7):505-8. PubMed ID: 7542426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]